{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:36:49Z","timestamp":1787071009842,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.4103\/idoj.idoj_446_23","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T01:00:37Z","timestamp":1719363637000},"page":"673-674","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["\u201cImmunopeeling\u201d Using Imiquimod for Xeroderma Pigmentosum"],"prefix":"10.4103","volume":"15","author":[{"given":"Vishal","family":"Gaurav","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somesh","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"2","DOI":"10.7573\/dic.2022-2-5","article-title":"Xeroderma pigmentosum:An updated review","volume":"11","author":"Leung","year":"2022","journal-title":"Drugs Context"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1524-4725.2000.99197.x","article-title":"Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses:An update and comparison","volume":"26","author":"Chiarello","year":"2000","journal-title":"Dermatol Surg"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"176","DOI":"10.25259\/IJDVL_431_19","article-title":"Therapeutics of xeroderma pigmentosum:A PRISMA-compliant systematic review","volume":"87","author":"de","year":"2021","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/01.prs.0000184345.09254.61","article-title":"Preliminary results after face peels using Aldara cream 5% (imiquimod)","volume":"116","author":"Prado","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jaci.2017.07.045","article-title":"Toll-like receptor 7\/8 agonists stimulate plasmacytoid dendritic cells to initiate TH17-deviated acute contact dermatitis in human subjects","volume":"141","author":"Garzorz-Stark","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","article-title":"Advanced characterization of imiquimod-induced psoriasis-like mouse model","volume":"12","author":"Jabeen","year":"2020","journal-title":"Pharmaceutics"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1525-1470.2008.00727.x","article-title":"Multiple basal cell carcinomas in xeroderma pigmentosum treated with imiquimod 5% cream","volume":"25","author":"Malhotra","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"R8-20240828","first-page":"e79","article-title":"Effects of topical application of betamethasone on imiquimod-induced psoriasis-like skin inflammation in mice","volume":"62","author":"Mori","year":"2016","journal-title":"Kobe J Med Sci"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bph.15983","article-title":"Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A","volume":"180","author":"Zhang","year":"2023","journal-title":"Br J Pharmacol"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/jamadermatol.2022.5261","article-title":"Prevention of skin cancers with topical calcipotriol and fluorouracil in patients with xeroderma pigmentosum","volume":"159","author":"Kim","year":"2023","journal-title":"JAMA Dermatol"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_446_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:18Z","timestamp":1787067618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_446_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_446_23","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"assertion":[{"value":"2023-06-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}